Please use this identifier to cite or link to this item: https://hdl.handle.net/10137/7192
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPoole, Alexis Pen
dc.contributor.authorAnstey, Jamesen
dc.contributor.authorBellomo, Rinaldoen
dc.contributor.authorBiradar, Vishwanathen
dc.contributor.authorDeane, Adam Men
dc.contributor.authorFinfer, Simon Ren
dc.contributor.authorFinnis, Mark Een
dc.contributor.authorFrench, Craig Jen
dc.contributor.authorKar, Palashen
dc.contributor.authorKruger, Peter Sen
dc.contributor.authorMaiden, Matthew Jen
dc.contributor.authorMårtensson, Johanen
dc.contributor.authorMcArthur, Colin Jen
dc.contributor.authorMcGuinness, Shay Pen
dc.contributor.authorSecombe, Paul Jen
dc.contributor.authorTobin, Antony Een
dc.contributor.authorUdy, Andrew Aen
dc.contributor.authorEastwood, Glenn Men
dc.date2018en
dc.date.accessioned2018-11-12T04:45:56Zen
dc.date.available2018-11-12T04:45:56Zen
dc.date.issued2018-10-19en
dc.identifier.citationAustralian critical care : official journal of the Confederation of Australian Critical Care Nurses 2018-10-19en
dc.identifier.issn1036-7314en
dc.identifier.urihttps://hdl.handle.net/10137/7192en
dc.description.abstractApproximately 9000 patients with type-2 diabetes mellitus (T2DM) are admitted to an intensive care unit (ICU) in Australia and New Zealand annually. For these patients, recent exploratory data suggest that targeting a more liberal blood glucose range during ICU admission may be safe and potentially beneficial. However, the current approach to blood glucose management of patients with T2DM in Australia and New Zealand ICUs is not well described, and there is uncertainty about clinician equipoise for trials of liberal glycaemic control in these patients. The aim is to describe self-reported blood glucose management in patients with T2DM by intensivists working in Australian and New Zealand ICUs and to establish whether equipoise exists for a trial of liberal versus standard glycaemic control in such patients. An online questionnaire of Australia and New Zealand intensivists conducted in July-September 2016. Seventy-one intensivists responded. Forty-five (63%) used a basic nomogram to titrate insulin. Sixty-six (93%) reported that insulin was commenced at blood glucose concentrations >10 mmol/L and titrated to achieve a blood glucose concentration between 6.0 and 10.0 mmol/L. A majority of respondents (75%) indicated that there was insufficient evidence to define optimal blood glucose targets in patients with T2DM, and 59 (83%) were prepared to enrol such patients in a clinical trial to evaluate a more liberal approach. A majority of respondents were uncertain about the optimal blood glucose target range for patients with T2DM and would enrol such patients in a comparative trial of conventional versus liberal blood glucose control.en
dc.description.provenanceMade available in DSpace on 2018-11-12T04:45:56Z (GMT). No. of bitstreams: 0 Previous issue date: 2018-10-19en
dc.language.isoengen
dc.subjectAttitudeen
dc.subjectBlood glucoseen
dc.subjectCritical careen
dc.subjectCritical illnessen
dc.subjectDiabetes mellitusen
dc.subjectIntensive care unitsen
dc.subjectSurveys and questionnairesen
dc.subjectType 2en
dc.titleOpinions and practices of blood glucose control in critically ill patients with pre-existing type 2 diabetes in Australian and New Zealand intensive care units.en
dc.typeJournal Articleen
dc.identifier.journaltitleAustralian critical care : official journal of the Confederation of Australian Critical Care Nursesen
dc.identifier.doi10.1016/j.aucc.2018.09.001en
dc.identifier.pubmedidhttps://www.ezpdhcs.nt.gov.au/login?url=https://www.ncbi.nlm.nih.gov/pubmed/30348487en
dc.identifier.affiliationDiscipline of Acute Care Medicine, University of Adelaide, Australia; Department of Intensive Care, Royal Adelaide Hospital, Australia. Electronic address: Alex.Poole@sa.gov.au..en
dc.identifier.affiliationDepartment of Intensive Care, Royal Melbourne Hospital, Australia..en
dc.identifier.affiliationDepartment of Intensive Care, Austin Hospital, Australia..en
dc.identifier.affiliationDepartment of Intensive Care, Lyell McEwin Hospital, Australia..en
dc.identifier.affiliationDepartment of Intensive Care, Royal Melbourne Hospital, Australia..en
dc.identifier.affiliationThe George Institute for Global Health, University of New South Wales, Sydney, Australia..en
dc.identifier.affiliationDepartment of Intensive Care, Royal Adelaide Hospital, Australia..en
dc.identifier.affiliationDepartment of Intensive Care, Western Health, Australia..en
dc.identifier.affiliationDiscipline of Acute Care Medicine, University of Adelaide, Australia; Department of Intensive Care, Royal Adelaide Hospital, Australia..en
dc.identifier.affiliationDepartment of Intensive Care, Princess Alexandra Hospital, Australia; School of Medicine, University of Queensland, Australia..en
dc.identifier.affiliationDepartment of Intensive Care, Geelong Hospital, Australia..en
dc.identifier.affiliationDepartment of Intensive Care, Austin Hospital, Australia..en
dc.identifier.affiliationDepartment of Critical Care Medicine, Auckland District Health Board, Australia..en
dc.identifier.affiliationCardiothoracic and Vascular Intensive Care and High Dependency Unit, Auckland District Health Board, Australia..en
dc.identifier.affiliationDepartment of Intensive Care, Alice Springs Hospital, Australia..en
dc.identifier.affiliationDepartment of Intensive Care, St Vincent's Hospital, Melbourne, Australia..en
dc.identifier.affiliationDepartment of Intensive Care, The Alfred Hospital, Australia..en
dc.identifier.affiliationDepartment of Intensive Care, Austin Hospital, Australia..en
dc.identifier.pubmedurihttps://www.ezpdhcs.nt.gov.au/login?url=https://www.ncbi.nlm.nih.gov/pubmed/30348487en
Appears in Collections:(a) NT Health Research Collection

Files in This Item:
There are no files associated with this item.


Items in ePublications are protected by copyright, with all rights reserved, unless otherwise indicated.